ASX pot stocks are getting high after TGA interim ruling
FreshLeaf has access to full product details for most medicinal cannabis products available in the marketplace in Australia.


Cannabis stocks were one of the rare groups in the green on a dismal day for the ASX on Wednesday following an interim ruling by the Therapeutic Goods Administration that could boost the industry.

The TGA is proposing to allow Australians to obtain low-dose cannabinoid (CBD) oils and pills from pharmacists, rather than forcing them to obtain a doctor’s prescription.

“It is a big deal,” Cassandra Hunt, managing director of FreshLeaf Analytics in North Sydney, said. “We expect it will expand the market of people who use medicinal cannabis products.”

Read full article –